Literature DB >> 10589636

A comparison of levobupivacaine 0.125%, fentanyl 4 microg/mL, or their combination for patient-controlled epidural analgesia after major orthopedic surgery.

D J Kopacz1, N E Sharrock, H W Allen.   

Abstract

UNLABELLED: Levobupivacaine, the isolated S(-) isomer of bupivacaine, is less cardiotoxic than racemic bupivacaine in animal studies. We studied the effectiveness of patient-controlled epidural analgesia (PCEA) with either levobupivacaine 0.125% or fentanyl 4 microg/mL alone, or a combination of levobupivacaine and fentanyl in 65 patients after total joint arthroplasty in a prospective, random, double-blinded fashion. Intraoperatively, all patients received 20 mL of 0.75% levobupivacaine. Study medication was infused at an initial rate of 4 mL/h, with additional medication available on patient demand (2 mL/10 min). The combination of levobupivacaine and fentanyl produced better analgesia (longer time to first PCEA request; P = 0.007 combination versus fentanyl and P = 0.006 combination versus levobupivacaine) than either drug alone. Patients in the levobupivacaine groups had appreciable sensory blockade to pinprick with minimal motor impairment. Resting and dynamic visual analog scale pain scores were lower in the combination group than in the plain fentanyl group at 6 (P = 0.022 and 0.036) and 12 h (P = 0.002 and 0.001). The 24-h overall patient- and investigator-rated visual analog scale pain scores were also lower in the combination group (resting P = 0.007, dynamic P = 0.005). There was no significant difference among the groups in the incidence of postoperative nausea (26.2%), pruritus (9.2%), hypotension (23.1%), or sedation (0%). We conclude that the analgesic effects of levobupivacaine 0.125% and fentanyl (4 microg/mL) are additive and beneficial for the management of orthopedic surgical pain by the PCEA method. Patients in this study began demand-dosing later, reported lower pain scores, and had no greater risk of adverse events than those who were given either levobupivacaine or fentanyl alone. IMPLICATIONS: We demonstrated a significant additive effect of the combination of levobupivacaine (0.125%) and fentanyl (4 microg/mL), compared with either drug alone, when using patient-controlled epidural analgesia in patients after total joint arthroplasty.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589636     DOI: 10.1097/00000539-199912000-00034

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

Review 1.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

2.  Investigating a Needle-Based Epidural Procedure in Obstetric Anesthesia.

Authors:  Eva K Lee; Haozheng Tian; Jinha Lee; Xin Wie; John Neeld; K Doug Smith; Alan R Kaplan
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

Review 3.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Levobupivacaine: a review of its pharmacology and use as a local anaesthetic.

Authors:  R H Foster; A Markham
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  The authors respond.

Authors:  G Ulufer Sivrikaya; Ayse Hanci
Journal:  Curr Ther Res Clin Exp       Date:  2011-10

6.  Additional pain relieving effect of intraoperative periarticular injections after simultaneous bilateral TKA: a randomized, controlled study.

Authors:  In Jun Koh; Yeon Gwi Kang; Chong Bum Chang; Sae Kwang Kwon; Eun Seok Seo; Sang Cheol Seong; Tae Kyun Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-01-30       Impact factor: 4.342

Review 7.  Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.

Authors:  Chantal A A Heppolette; Derek Brunnen; Sohail Bampoe; Peter M Odor
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

8.  Patient-controlled epidural analgesia after Caesarean section: levobupivacaine 0.15% versus ropivacaine 0.15% alone or combined with fentanyl 2 µg/ml: a comparative study.

Authors:  Paraskevi Matsota; Chrysanthi Batistaki; Stylliani Apostolaki; Georgia Kostopanagiotou
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

9.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

10.  Clinical profile of levobupivacaine in regional anesthesia: A systematic review.

Authors:  Sukhminder Jit Singh Bajwa; Jasleen Kaur
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.